Delivery Order SPE2DB24D2215-SPE2DB25FGTCU
- Not listed
- The Defense Logistics Agency awarded a $1,341.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Protopam Chloride 1 GM vials, with an ultimate completion date of July 25, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement needs, particularly...
- The Defense Logistics Agency awarded a $2,263.89 firm fixed price delivery order to AmerisourceBergen Drug Corp for Protopam Chloride 1 GM vials, with an ultimate completion date of August 1, 2025. This competitive award includes no set-aside designation and represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform this delivery order...
- The U.S. Department of Defense Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $2,900.50 for Protopam Chloride 1 GM vials, with an ultimate completion date of July 22, 2025. This non-set-aside contract was competitively awarded on a firm fixed-price basis. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical procurement needs across military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Protopam Chloride 1 GM vials with a ceiling value of $8,760.11 under a firm fixed-price contract. This award, issued on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a child delivery order under the contractor's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order carries no set-aside...
- The Defense Logistics Agency awarded a $2,446.99 delivery order to AmerisourceBergen Drug Corp for Protopam Chloride 1 GM vials, with an ultimate completion date of September 9, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,070.97 to AmerisourceBergen Drug Corp for Protopam Chloride 1 GM vials, with an ultimate completion date of September 11, 2025. This contract utilizes firm fixed pricing and was awarded on a non-set-aside, competitive basis. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a $1,451.96 delivery order to AmerisourceBergen Drug Corp on June 9, 2025, for the supply of Protopam Chloride 1 GM vials, with completion scheduled for June 10, 2025. This firm fixed-price contract represents a non-set-aside award made through open competition. The contractor will perform this work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,939.47 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Protopam Chloride 1 GM vials, with an ultimate completion date of September 18, 2025. This non-set-aside contract was competitively awarded on September 17, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Protopam Chloride is a critical antidote used in emergency medical situations, particularly for organophosphate poisoning treatment in...
- The Defense Logistics Agency Medical Supply Chain awarded a $1,451.96 delivery order to AmerisourceBergen Drug Corp for Protopam Chloride 1 GM vials on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order was placed with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Protopam Chloride is a cholinesterase reactivator used in medical countermeasures...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Protopam Chloride 1 GM vials with a ceiling value of $5,777.60. This firm fixed-price contract, which has an ultimate completion date of August 7, 2025, represents a routine pharmaceutical procurement supporting the federal medical supply chain. The award was made through open competition with no set-aside designation, leveraging AmerisourceBergen's established relationship...
- SPE2DB24D2215Indefinite Delivery Contract
- SPE2DB24D2215-SPE2DB25FGTCUDelivery Order
The Defense Logistics Agency awarded a $5,960.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Protopam Chloride 1 GM vials, with an ultimate completion date of July 24, 2025. This is a non-set-aside contract, competitively awarded to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor specializing in medical procurement for military and veteran healthcare systems. Protopam Chloride (pralidoxime) is an antidote used in emergency treatment of certain pesticide and nerve agent poisonings, making it an essential pharmaceutical commodity for military medical readiness. The company's extensive portfolio of federal contracts demonstrates its capability to fulfill diverse medical supply requirements through open competition, with delivery orders consistently structured as firm fixed-price transactions. This award supports the Defense Health Agency and broader military healthcare operations through DLA's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 7/23/25 |